Product Pathways - Lymphocyte Signaling
Btk (D3H5) Rabbit mAb (Biotinylated) #12624
|12624S||100 µl (10 western blots)||---||In Stock||---|
|12624||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
|W||1:1000||Human, Mouse||Endogenous||77||Rabbit IgG|
Species cross-reactivity is determined by western blot using the unconjugated antibody.
Applications Key: W=Western Blotting
Species predicted to react based on 100% sequence homology: Rat, Hamster, Monkey, Bovine, Dog, Pig, Horse.
Specificity / Sensitivity
Btk (D3H5) Rabbit mAb (Biotinylated) recognizes endogenous levels of total Btk protein.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Asp195 of human Btk protein.
This Cell Signaling Technology antibody is conjugated to biotin under optimal conditions. The biotinylated antibody is expected to exhibit the same species cross-reactivity as the unconjugated Btk (D3H5) Rabbit mAb #8547.
Bruton's tyrosine kinase (Btk) is a member of the Btk/Tec family of cytoplasmic tyrosine kinases. Like other Btk family members, it contains a pleckstrin homology (PH) domain and Src homology SH3 and SH2 domains. Btk plays an important role in B cell development (1,2). Activation of B cells by various ligands is accompanied by Btk membrane translocation mediated by its PH domain binding to phosphatidylinositol-3,4,5-trisphosphate (3-5). The membrane-localized Btk is active and associated with transient phosphorylation of two tyrosine residues, Tyr551 and Tyr223. Tyr551 in the activation loop is transphosphorylated by the Src family tyrosine kinases, leading to autophosphorylation at Tyr223 within the SH3 domain, which is necessary for full activation (6,7). The activation of Btk is negatively regulated by PKCβ through phosphorylation of Btk at Ser180, which results in reduced membrane recruitment, transphosphorylation, and subsequent activation (8). The PKC inhibitory signal is likely to be a key determinant of the B cell receptor signaling threshold to maintain optimal Btk activity (8).
- Khan, W.N. (2001) Immunol. Res. 23, 147-156.
- Lewis, C.M. et al. (2001) Curr. Opin. Immunol. 13, 317-325.
- Salim, K. et al. (1996) EMBO J. 15, 6241-6250.
- Rameh, L.E. et al. (1997) J. Biol. Chem. 272, 22059-22066.
- Varnai, P. et al. (1999) J. Biol. Chem. 274, 10983-10989.
- Rawlings, D.J. et al. (1996) Science 271, 822-825.
- Park, H. et al. (1996) Immunity 4, 515-525.
- Kang, S.W. et al. (2001) EMBO J. 20, 5692-5702.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.